about
Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel DiseaseCurrent approaches for optimizing the benefit of biologic therapy in ulcerative colitisOverview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseasesCurrent and Emerging Uses of Statins in Clinical Therapeutics: A ReviewReview article: dose optimisation of infliximab for acute severe ulcerative colitis.Periodontal manifestations of inflammatory bowel disease: emerging epidemiologic and biologic evidence.Potential role of nutraceutical compounds in inflammatory bowel diseaseDiffering Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease.Association of ATG16L1 gene haplotype with inflammatory bowel disease in Indians.Propionibacterium freudenreichii Surface Protein SlpB Is Involved in Adhesion to Intestinal HT-29 CellsStability Profiles and Therapeutic Effect of Cu/Zn Superoxide Dismutase Chemically Coupled to O-Quaternary Chitosan Derivatives against Dextran Sodium Sulfate-Induced Colitis.Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD CohortEx vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease.Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population.Immunopathogenesis of granulomas in chronic autoinflammatory diseases.Protective Effect of Daikenchuto on Dextran Sulfate Sodium-Induced Colitis in Mice.MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expressionMadecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway.Population-specific genome-wide mapping of expression quantitative trait loci in the colon of Han Chinese.Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease.The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.Hydrodynamic IL10 Gene Transfer in Human Colon: Results from an "EX VIVO" Study with Potential Clinical Application in Crohn's Disease.Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro.The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence?Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Macrophage Subset Expressing CD169 in Peritoneal Cavity-Regulated Mucosal Inflammation Together with Lower Levels of CCL22.The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.Endocannabinoids in the gastrointestinal tract.Acute severe ulcerative colitis: from pathophysiology to clinical management.Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis.The autoimmunity-oral microbiome connection.Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same?Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.Resident macrophages in the healthy and inflamed intestinal muscularis externa.
P2860
Q26741037-98159F57-E7B2-4DA8-9815-029A463EF5B4Q26745712-769CF19D-5196-4676-A249-40BA0899D040Q28069372-25BB2EC9-C22E-47B6-8E59-A3C8C760EFA9Q28076346-4F9E2557-1CA4-44FF-9823-D19308AE3F1BQ30239077-B514C1FF-F493-4BBD-AB6E-B91D42A574F5Q30245122-95D09BA1-AC40-4724-A8BF-18B15DA05C58Q33572633-458A35E4-368B-4B07-A53A-2C6FD2688416Q33658943-9F55D4C6-11BA-4913-8406-8A88344EF5A1Q33708244-2E12B842-7423-41F4-94E7-B57729304708Q33774725-A230E7F9-EF72-461E-9754-2E7DC3FF6313Q33838405-1C2C80B5-7F74-42C4-A855-168D06897381Q36088790-0182E416-789B-48DC-A67E-51BC0101E7CDQ36221213-ED66C38D-A74D-4B0A-B468-84170DD9C15FQ36260666-27D57C2A-72A5-441B-B2C9-E611F748F44AQ37223511-1369E3B9-1098-4BFE-ADC7-BBE4ED3AADFFQ37411301-06D1C067-57F7-4596-B344-B59B51707FCCQ37529278-1A4678DA-1E09-40EA-9A91-53B0A293C294Q37538526-CDD4C5D1-28B5-4B3C-849E-8FDFA52079CAQ37624817-77704FDC-C782-449C-B0DC-C1B9F3D2156DQ37644020-885DB4C0-EE7C-4D72-AF24-988949192E44Q37745452-20D2B3F1-C6E5-48F5-8926-8A6C5A00D773Q38443685-04C7AE24-AE76-4194-8585-30C40C650D7DQ38626073-42BE40AC-E0CA-47EF-9B80-E49BBD25D1AFQ38648792-EEC05C4D-6250-4AC9-9AD6-C35FC794ABAFQ38672414-38D6DAE1-B296-410C-A616-CE5D219A3FFEQ38678884-B17C9804-EE9A-4736-B182-5C22F20D130CQ38685792-B55B3A68-8499-494F-A98D-C3EA19948190Q38700513-C00971C1-7E6A-4199-A3F4-FBF5C3B5551BQ38724401-4AB07F3E-9686-4A64-813E-FD1B4110F73AQ38773024-27C146B4-F0FD-43BA-A650-245B99A597CCQ38794312-8CBFC933-EA26-4366-92E5-22706EADBD50Q38807625-927CE111-5723-4A5F-AA01-6B92EAE170A2Q38927461-BD748B5D-7950-4686-8E28-6E90A3D42520Q38931168-1EB7E35B-267E-4B04-9871-033EE8C7FB7FQ38942561-F55F186A-E7D0-4A34-AF1E-18946712D18AQ38955406-D684FCA8-21B9-4C81-8BC8-59653724EBB8Q38975179-70CA8104-9B6B-4E1C-B4DA-D9274800DF76Q38982297-C499E7C0-0452-497D-9336-6685849140FCQ39127400-E9B4138F-03C5-407C-ABA0-39EC9B3E66C4Q39150054-76AC5CDB-7407-401B-984B-2B0776D49785
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunopathogenesis of IBD: current state of the art.
@ast
Immunopathogenesis of IBD: current state of the art.
@en
type
label
Immunopathogenesis of IBD: current state of the art.
@ast
Immunopathogenesis of IBD: current state of the art.
@en
prefLabel
Immunopathogenesis of IBD: current state of the art.
@ast
Immunopathogenesis of IBD: current state of the art.
@en
P2860
P1476
Immunopathogenesis of IBD: current state of the art
@en
P2093
Claudio Fiocchi
P2860
P2888
P356
10.1038/NRGASTRO.2015.186
P407
P577
2015-12-02T00:00:00Z